title: 1,5-Dimethyl-3-[(3-phenyl-4,5-dihydro-1,2-oxazol-5-yl)meth-yl]-1H-1,5-benzodiazepine-2,4(3H,5H)-dione.
abstract: The reaction of 3-allyl-1,5-dimethyl-1,5-benzodiazepine-2,4-dione and benzaldoxime leads to the title compound, C(21)H(21)N(3)O(3). The mol-ecular structure is built up from two fused six- and seven-membered rings linked to a chain including a five- and six-membered ring (isoxazoline and phen-yl) via a methyl-ene group. The seven-membered ring displays a boat conformation. The dihedral angle between the two six-membered rings is 74.3 (1)°.
authors: Rachida
authors: R
authors: Dardouri
authors: Youssef
authors: Y
authors: Kandri Rodi
authors: Nathalie
authors: N
authors: Saffon
authors: Lahcen
authors: L
authors: El Ammari
authors: El Mokhtar
authors: el M
authors: Essassi
references: J Med Chem. 1998 Dec 17;41(26):5272-86
references: 9857095
references: Bioorg Med Chem. 2006 Feb 1;14(3):758-75
references: 16214350
references: Eur J Med Chem. 2008 Oct;43(10):2178-88
references: 17959273
references: Neuropeptides. 2007 Oct;41(5):307-20
references: 17637475
references: Pharmacol Res. 2001 May;43(5):445-52
references: 11394936
references: Acta Crystallogr A. 2008 Jan;64(Pt 1):112-22
references: 18156677
references: Acta Crystallogr Sect E Struct Rep Online. 2009 Nov 21;65(Pt 12):o3150
references: 21578869
references: J Neurosci. 1997 May 15;17(10):3467-75
references: 9133372